{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:01:26Z","timestamp":1774645286046,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR058005"],"award-info":[{"award-number":["R01 AR058005"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2 RR025760"],"award-info":[{"award-number":["KL2 RR025760"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.bone.2014.06.036","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T15:45:12Z","timestamp":1404488712000},"page":"139-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium"],"prefix":"10.1016","volume":"67","author":[{"given":"Austin M.","family":"Reilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie K.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon M.","family":"Moe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6477-0520","authenticated-orcid":false,"given":"Shoji","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.06.036_bb0005","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.bone.2014.06.036_bb0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajmg.a.33337","article-title":"Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations","volume":"152A","author":"Ichikawa","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.bone.2014.06.036_bb0015","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2004-2302","article-title":"A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive","volume":"90","author":"Ichikawa","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.06.036_bb0020","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis","volume":"117","author":"Ichikawa","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.06.036_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pag\u00e8s","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bone.2014.06.036_bb0030","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","article-title":"A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis","volume":"90","author":"Larsson","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.06.036_bb0035","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation","volume":"281","author":"Kato","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.06.036_bb0040","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.06.036_bb0045","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bone.2014.06.036_bb0050","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2014.06.036_bb0055","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2006-1825","article-title":"Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations","volume":"92","author":"Ichikawa","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.06.036_bb0060","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2006-1247","article-title":"Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene","volume":"91","author":"Ichikawa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.06.036_bb0065","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2009-0961","article-title":"Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis","volume":"94","author":"Bergwitz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.06.036_bb0070","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00198-008-0775-z","article-title":"A case of familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features","volume":"20","author":"Dumitrescu","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2014.06.036_bb0075","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/jc.2006-0305","article-title":"The role of mutant UDP-N-acetyl-alpha-d-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis","volume":"91","author":"Garringer","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.06.036_bb0080","doi-asserted-by":"crossref","first-page":"247S","DOI":"10.1016\/S8756-3282(95)80001-8","article-title":"Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide","volume":"16","author":"Yamaguchi","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.036_bb0085","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/ndt\/gfh781","article-title":"Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure","volume":"20","author":"Eto","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bone.2014.06.036_bb0090","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/ndt\/14.5.1195","article-title":"Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine","volume":"14","author":"Katai","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bone.2014.06.036_bb0095","first-page":"F15","article-title":"Nicotinamide as a rapid-acting inhibitor of renal brush-border phosphate transport","volume":"255","author":"Wu","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bone.2014.06.036_bb0100","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI110163","article-title":"Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat","volume":"67","author":"Kempson","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.06.036_bb0105","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04211007","article-title":"A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients","volume":"3","author":"Cheng","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2014.06.036_bb0110","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00482.x","article-title":"Nicotinamide suppresses hyperphosphatemia in hemodialysis patients","volume":"65","author":"Takahashi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2014.06.036_bb0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/089686080902900515","article-title":"The effect of oral niacinamide on plasma phosphorus levels in peritoneal dialysis patients","volume":"29","author":"Young","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.bone.2014.06.036_bb0120","first-page":"58","article-title":"Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial","volume":"31","author":"Shahbazian","year":"2011","journal-title":"Nefrologia"},{"key":"10.1016\/j.bone.2014.06.036_bb0125","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/en.2008-0877","article-title":"Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression","volume":"150","author":"Ichikawa","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.06.036_bb0130","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1210\/en.2011-1137","article-title":"Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis","volume":"152","author":"Ichikawa","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.06.036_bb0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1020884312053","article-title":"Food intake, water intake, and drinking spout side preference of 28 mouse strains","volume":"32","author":"Bachmanov","year":"2002","journal-title":"Behav Genet"},{"key":"10.1016\/j.bone.2014.06.036_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2242","article-title":"High dietary phosphate intake induces development of ectopic calcifications in a murine model of familial tumoral calcinosis","author":"Ichikawa","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.036_bb0145","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2012.12.035","article-title":"Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"61","author":"Budoff","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.bone.2014.06.036_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosissup.2012.10.036","article-title":"Nicotinic acid as a lipid-modifying drug\u2013a review","volume":"14","author":"Julius","year":"2013","journal-title":"Atheroscler Suppl"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214002452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214002452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T00:39:50Z","timestamp":1598056790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214002452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":30,"alternative-id":["S8756328214002452"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.06.036","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}